Summary of the updated prospectus of Huitianfu Global Healthcare Hybrid Securities Investment Fund
This document is the updated prospectus summary (2018 No. 1) of the Huitianfu (China Universal) Global Healthcare Hybrid Securities Investment Fund, a contract-type open-ended hybrid securities investment fund registered with the China Securities Regulatory Commission. The fund contract took effect on August 16, 2017, with Industrial and Commercial Bank of China as custodian. The update cutoff date is February 16, 2018, and the financial data and net value performance cited are as of December 31, 2017 (unaudited).
The fund invests in both domestic and overseas markets, mainly in stocks of companies related to the global healthcare industry, using a bottom-up stock selection strategy combined with prudent asset allocation. Stock investment accounts for 60%-95% of fund assets, at least 80% of non-cash fund assets go to global healthcare-related stocks, and cash plus government bonds maturing within one year total no less than 5% of net fund assets. The document also describes the fund's risk-return characteristics, investment scope, and stock selection process. This manual is written in Chinese.
The fund contract officially took effect on August 16, 2017.
Stock investment accounts for 60%-95% of fund assets, and at least 80% of non-cash fund assets must be invested in global healthcare-related company stocks.
Cash plus government bonds maturing within one year must total no less than 5% of net fund assets.
The fund uses a bottom-up approach to select stocks of global healthcare-related companies, seeking steady medium- to long-term appreciation of fund assets under strict risk management.